Chairperson''s Welcome And Opening Remarks
Dr. Ajit Dangi, Director General
Organisation of Pharmaceutical Producers of India
Overview of Asia''s Recent updates and Developments in the Pharmaceuticals Industry:
What''s new for 2003?
- Overview of trends and developments in Asia''s healthcare industry
- Global market place trends and developments
- Asia''s leading markets: Demographics, trends, potential and opportunities
- Changes in the healthcare /consumer environment and the impact on the business of Pharmaceuticals
- New challenges facing Pharmaceutical companies in Asia
Dr. Stephen Phua, Area Vice President, IMS Health Asia
Regulatory Evolution in Asia: A Look at recent and impending changes in regulatory systems
- Regulatory updates for Korea, Taiwan, China and ASEAN
- New regulations in Drug Master File Korea
- Overview of harmonization efforts and developments in the region
- Regulatory harmonization in common technical dossier ASEAN
Roy Shyng, Regional Regulatory Affairs Director, Pharmacia
India: An Emerging Pharmaceutical Powerhouse
- Market dynamics and Potential
- Intellectual Property Rights (IPR) scenario
- Regulatory Issues
- Outsourcing opportunities
- Research and Development
- Self medication (OTC) trends
- The future of biotechnology
- Strategic options post - 2003 (when IPR regime comes into force)
- Business models and case studies
Dr. Ajit Dangi, Director General, Organization of Pharmaceutical Producers of India
Delivery Systems: India''s Strategic Tool For Growth
- SWOT of India''s potential in R&D
- Shortlist of potential strategies for growth
- Introduction to new drug delivery systems
- Infrastructure for delivery systems
- Potential technologies for the future in delivery systems
V. Madhusudan, Executive Vice President & Head, Global R&D, India, Banner Pharmacaps, India
A look at pharmaceuticals in the Philippines
- Drug utilization
- Requirements for registration of Pharmaceuticals
- Procedure for approval of new drug applications
- Evaluation of clinical studies
- Post-marketing surveillance
Virginia Francia C. Laboy, Food-Drug Regulation Officer, Bureau of Food and Drugs, Philippines
Changing landscape in the healthcare market in China
- Government regulations and policies in the healthcare sector
- Latest developments in the healthcare sector
- Overview of China''s drug distribution system
- Impact of the healthcare reform on drug sales and distribution
- Impact of WTO on drug distribution
- Entry strategies for foreign Pharmaceutical companies
Anthony Cheung, Director China Concept Consulting, Hong Kong
* Updates on Pharmaceutical Regulatory Developments in PRC
* New PRC intellectual property development
Tan Loke Khoon & Li Chiang Ling, Partners, Baker & McKenzie, Hong Kong
DAY 2: 11 MARCH 2003 TUESDAY
Chairperson''s Welcome and Opening Remarks
Alan Chit, Executive Director, HPC Healthcare & Pharma Consulting International, Hong Kong
Building Blocks, advance pharmaceutical intermediates (API), Bulk or Formulation: Where is the future of Asian Pharmaceuticals?
- Overview of world wide trends
- Manufacture of drugs in Asia
- Importance of quality control, Good Manufacturing Practices (GMP) and Intellectual Property
Dr. Mercier Claude, Asia Pacific Business Director, Rhodia, Hong Kong
Pharmaceutical Development Outsourcing
- Comparison of global and Asian trends in outsourcing: A more tactical approach in Asia
- The Quintiles experience
- Types of services outsourced
- Developing capability across Asia: Where to start
- The role of outsourcing: From people to products
- Partnerships: Examples of working together
Anthony Bishop, Business Development Manger, Quintiles Asia Pacific
Strategies for Growth in the Asian Market
- Leveraging on synergies and opportunities
- Maintaining growth in a slow moving market
- Dealing with parallel trade and price controls
- Pricing strategies in the context of parallel trade and cost containment measures
Alan Chit, Executive Director, HPC Healthcare & Pharma Consulting International, Hong Kong
Pharmaceutical E-Business: IT Applications and the impact on sales force effectiveness
- Understanding the Pharmaceutical value chain
- Identifying areas of improving sales force effectiveness
- Seed of market information: A key factor for success
- Key factors for territory management systems
- Leveraging productivity by sophisticated decision support systems
Dr. Guido Oelkers, Vice President, DKSH Healthcare, Thailand &
Peter Huang, Regional Head, Strategy Development DKSH Healthcare, Thailand
Clinical Trials in drug development in Asia: what does the future hold?
- Ethics: Are Ethics Committees/Institutional Review Boards up to the task?
- Guidelines : Are we practicing good clinical practice?
- The science of trails: Do our investigators know enough about methodology?
- Logistics: Is the infrastructure in place?
A/Prof Jorgen Seldrup, Director, Clinical Trials and Epidemiology Research Unit, National Medical Research Council
Commercializing Biotechnology and Biomedical Products
- Steps to commercializing technology
- Importance of securing Intellectual Property
- Funding issues to drive commercialization process
- Licensing and collaborative arrangements
Dr Tan Sze-Wee, Managing Director, Rockeby Biomed
Getting your branding strategies right for the Asian Pharmaceutical market
- Difference between a product and a brand
- Linking emotional brand attributes to functional product attributes
- Understanding the emotional relationship that doctors and patients have with a brand
- Developing a blueprint for the brand
- Working with global brand positioning and making it suitable for our market
- Monitoring the success of a brand over time
Stephen Potts, Regional Director, Healthcare, Taylor Nelson Sofres
What are the opportunities for expansion in Asia''s Pharmaceutical industry in the next 3 years? : Panel Discussion
- Government pressures and its effects
- Regulatory developments
- Mounting globalisation and consolidation
- Consolidation demands and expectations
- Sustainability of pricing
Moderator
Alan Chit, Executive Director, HPC Healthcare & Pharma Consulting International, Hong Kong
Panelists
Dr. Mercier Claude, Asia Pacific Business Director, Rhodia, Hong Kong
Anthony Cheung, Director, China Concept Consulting, Hong Kong
Dr. Ajit Dangi, Director General, Organization of Pharmaceutical Producers of India